Group items tagged

Primary-care medicine is as much art as it is science, but clinicians sometimes rely too heavily on the former when it comes to prescribing antibiotics. Nowhere is this truer than in the treatment of respiratory tract infections (RTIs). Most cases of bronchitis are caused by viruses, but many clinicians prescribe antibiotics at their patients' insistence. Patients may explain that they are going on a long-planned vacation and just can't afford to be sick, or they are getting married that weekend and desperately need to get over an annoying cold.

Onions are known for therapeutic benefits since ancient times. Even the World Health Organization has confirmed that onions are beneficial for people with low hunger and atherosclerosis. Health experts acknowledge the fact that onions are very good treatments for patients with chronic asthma, allergic bronchitis, common cough cough and cold syndrome.

Two Indian pharmaceutical companies, Cipla and Glenmark, are pulling back certain products from the American market due to manufacturing concerns, according to the US Food and Drug Administration (USFDA). A New Jersey-based subsidiary of Cipla is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution due to "short fill", news agency PTI reported, quoting the latest Enforcement Report issued by the US health regulator. Produced at the company's Indore SEZ plant, this medication is used to manage symptoms associated with lung diseases, such as asthma, chronic bronchitis and emphysema. Cipla USA decided to recall the affected lot following complaints of less fill volume in respule and few drops of liquid observed in the intact pouch, the USFDA said, adding that the drug maker initiated the Class II recall in the US market on March 26 this year.

Asthma makes breathing difficult for more than 300 million people worldwide according to the WHO. Treat your bronchial asthma/ breathlessness/ wheezing/ respiratory allergy with Homeopathy at Dr. Batra's

PBR Staff Writer Published 01 May 2014 The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Incruse Ellipta (umeclidinium) for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic.

Health Benefits of Cardamom for Asthma Cardamom has long been used to treat asthma, bronchitis, and whooping cough. To relieve your asthma,...